Abstract
Purpose:
Persistent type 2 endoleaks (pT2ELs) following endovascular aortic aneurysm repair (EVAR) pose surveillance challenges. Although previous studies demonstrated that low D-dimer levels at single time points indicate lower risk of aneurysm enlargement (AnE), the value of longitudinal D-dimer monitoring remains unexplored. This study examined associations between D-dimer dynamics and AnE in patients with pT2ELs.
Methods:
This is a retrospective single-center cohort study. Consecutive patients undergoing elective EVAR (2007-2022) were reviewed. Inclusion criteria were isolated pT2ELs confirmed at 12 months, >2 years of follow-up, and available annual D-dimer data. Primary outcome was AnE (≥5 mm sac diameter increase) within 5 years. D-dimer trajectories were retrospectively classified as consistently low (<5.3 µg/mL throughout), transitioned to high (≥13.5 µg/mL at any point), or intermediate (all others). Analyses used multivariable trajectory-based Cox regression, time-dependent Cox regression, and generalized estimating equations (GEEs), adjusting for chronic kidney disease, inferior mesenteric artery patency, and number of patent lumbar arteries (≥6).
Results:
Among 118 patients, 43 (36.4%) experienced AnE. Kaplan-Meier analysis showed significantly lower freedom from AnE in the transitioned to high group (overall log-rank P = .002). In trajectory-based Cox regression, the transitioned to high group had significantly increased AnE risk versus the consistently low group (adjusted hazard ratio = 4.76, 95% confidence interval [CI]: 1.62-14.00, P = .005). Generalized estimating equation sensitivity analysis confirmed a dose-response relationship, with high D-dimer showing the strongest association (odds ratio 3.45, 95% CI: 1.69-7.05, P < .001).
Conclusion:
D-dimer dynamics were associated with AnE in patients with pT2ELs. Multiple complementary analyses demonstrated consistent dose-dependent associations. Retrospective trajectory classification defined distinct prognostic phenotypes: patients maintaining levels <5.3 µg/mL demonstrated superior sac stability, whereas elevations ≥13.5 µg/mL identified a higher-risk group. These findings support a biomarker-guided dynamic surveillance strategy, pending prospective validation before clinical deployment.
Clinical Impact
Current surveillance of persistent type 2 endoleaks relies solely on imaging, lacking validated biomarkers to guide follow-up. This retrospective study shows that longitudinal D-dimer trajectory patterns were independently associated with aneurysm enlargement over 5 years, and D-dimer levels at each annual visit were associated with enlargement risk in the subsequent year. A routinely available blood test may therefore complement imaging-based surveillance: levels below 5.3 µg/mL were associated with low enlargement risk, whereas elevations ≥13.5 µg/mL defined a higher-risk phenotype warranting closer follow-up. If prospectively validated, this biomarker-guided approach could support individualized surveillance and more efficient use of imaging resources.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
